MATERNAL SERUM-FREE BETA-HCG SCREENING - RESULTS OF STUDIES INCLUDING 480 CASES OF DOWN-SYNDROME

被引:52
作者
MACRI, JN
SPENCER, K
GARVER, K
BUCHANAN, PD
SAY, B
CARPENTER, NJ
MULLER, F
BOUE, A
机构
[1] OLDCHURCH HOSP,DEPT CLIN BIOCHEM,ROMFORD RM7 0BE,ESSEX,ENGLAND
[2] W PENN HOSP,PITTSBURGH,PA 15224
[3] GENECARE MED GENET CTR,CHAPEL HILL,NC 27514
[4] CHILDRENS MED CTR,TULSA,OK 74135
[5] HOP AMBROISE PARE,F-92104 BOULOGNE,FRANCE
[6] INSERM,U73,F-75016 PARIS,FRANCE
关键词
DOWN SYNDROME; SCREENING; FREE BETA;
D O I
10.1002/pd.1970140204
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The median maternal serum free beta human chorionic gonadotropin (hCG) multiple of the median (MOM) of 480 Down syndrome cases in the second trimester was 2.64, significantly greater than the reported median MOM of intact hCG (p<0.0001). In 234 of these cases from retrospective and prospective studies, the effectiveness of maternal serum free beta hCG was evaluated in combination with alpha-fetoprotein (AFP) and maternal age in second-trimester Down syndrome screening. Down syndrome detection in the gestational age range of 14-16 weeks was 82 per cent. In all gestational weeks (14-22), a 77.7 per cent Down syndrome detection rate was achieved. In prospective screening of 44272 patients under the age of 35 years, 69 per cent of Down syndrome cases were detected (73 per cent in gestational weeks 14-16). The false-positive rate for the prospective study was 3.8 per cent. The use of free beta hCG combined with maternal serum AFP and maternal age-related risk for Down syndrome in a screening population (i.e., women under 35 years) yields an improved detection efficiency over other protocols.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 20 条
[1]   ABNORMAL MATERNAL SERUM CHORIONIC-GONADOTROPIN LEVELS IN PREGNANCIES WITH FETAL CHROMOSOME-ABNORMALITIES [J].
BOGART, MH ;
PANDIAN, MR ;
JONES, OW .
PRENATAL DIAGNOSIS, 1987, 7 (09) :623-630
[2]  
CUCKLE H, 1992, BRIT MED J, V305, P1017, DOI 10.1136/bmj.305.6860.1017
[3]   PRENATAL SCREENING FOR DOWNS-SYNDROME WITH USE OF MATERNAL SERUM MARKERS [J].
HADDOW, JE ;
PALOMAKI, GE ;
KNIGHT, GJ ;
WILLIAMS, J ;
PULKKINEN, A ;
CANICK, JA ;
SALLER, DN ;
BOWERS, GB .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (09) :588-593
[4]  
Hook E B, 1977, Birth Defects Orig Artic Ser, V13, P123
[5]  
LARSEN J, 1992, American Journal of Obstetrics and Gynecology, V166, P350
[6]  
Macri J. N., 1992, American Journal of Human Genetics, V51, pA418
[7]   MATERNAL SERUM DOWN-SYNDROME SCREENING - FREE BETA-PROTEIN IS A MORE EFFECTIVE MARKER THAN HUMAN CHORIONIC-GONADOTROPIN [J].
MACRI, JN ;
KASTURI, RV ;
KRANTZ, DA ;
COOK, EJ ;
MOORE, ND ;
YOUNG, JA ;
ROMERO, K ;
LARSEN, JW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) :1248-1253
[8]   FREE BETA-CHORIONIC GONADOTROPIN - A CROSS-REACTIVITY STUDY OF 2 IMMUNOMETRIC ASSAYS USED IN PRENATAL MATERNAL SERUM SCREENING FOR DOWNS-SYNDROME [J].
MACRI, JN ;
SPENCER, K ;
ANDERSON, RW ;
COOK, EJ .
ANNALS OF CLINICAL BIOCHEMISTRY, 1993, 30 :94-98
[9]   CRITICAL ISSUES IN PRENATAL MATERNAL SERUM ALPHA-FETOPROTEIN SCREENING FOR GENETIC ANOMALIES [J].
MACRI, JN .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (02) :240-246
[10]   DUAL ANALYTE IMMUNOASSAY - A NEW APPROACH TO NEURAL-TUBE DEFECT AND DOWNS-SYNDROME SCREENING [J].
MACRI, JN ;
SPENCER, K ;
ANDERSON, R .
ANNALS OF CLINICAL BIOCHEMISTRY, 1992, 29 :390-396